Entrada Therapeutics (TRDA) Q3 2026 Earnings

12AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-1.06
-0.99
-0.92
-0.85

Details

Expected EPS
-1.049325
Actual EPS
N/A
Surprise EPS
1.05
Surprise Percent
+100%

Description

Entrada Therapeutics (TRDA) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts